Crossref
Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM
Transfuze a hematologie dnes · 2023
DOI: 10.48095/cctahd2023207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfuze a hematologie dnes, 2023. Verfasst von Kateřina Michnová.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Michnová, K. (2023). Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM. Transfuze a hematologie dnes. https://doi.org/10.48095/cctahd2023207
Vancouver
Michnová K. Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM. Transfuze a hematologie dnes. 2023. doi:10.48095/cctahd2023207
BibTeX
@article{Michnov2023,
author = {Michnová, Kateřina},
title = {Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM},
journal = {Transfuze a hematologie dnes},
year = {2023},
doi = {10.48095/cctahd2023207}
}
EUVIMED